Neurociencia del consumo y dependencia de sustancias psicoactivas
Neurociencia del consumo y dependencia de sustancias psicoactivas
Neurociencia del consumo y dependencia de sustancias psicoactivas
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5. BASES GENÉTICAS DE LAS FARMACODEPENDENCIAS<br />
Mad<strong>de</strong>n PA y colab. (1999) The genetics of smoking persistence in men and<br />
women: a multicultural study. Behavior Genetics, 29:423–431.<br />
Maes HH y colab. (1999) Tobacco, alcohol and drug use in eight- to sixteenyear-old<br />
twins: the Virginia Twin Study of Adolescent Behavioral Development.<br />
Journal of Studies on Alcohol, 60:293–305.<br />
Maezawa Y y colab. (1995) Alcohol-metabolizing enzyme polymorphisms and alcoholism<br />
in Japan. Alcoholism: Clinical and Experimental Research, 19:951–954.<br />
Marmot M (1997) Inequality, <strong>de</strong>privation and alcohol use. Addiction, 92(Suppl.<br />
1):S13–S20.<br />
Marteau TM, Lerman C (2001) Genetic risk and behavioural change. British<br />
Medical Journal, 322:1056–1059.<br />
Maruyama K y colab. (1999) Genotypes of alcohol-metabolizing enzymes in<br />
relation to alcoholic chronic pancreatitis in Japan. Alcoholism: Clinical and<br />
Experimental Research, 23(Suppl 4):S85–S91.<br />
Marzuk PM y colab. (1997) Poverty and fatal acci<strong>de</strong>ntal drug overdoses of<br />
cocaine and opiates in New York City: an ecological study. American Journal of<br />
Drug and Alcohol Abuse, 23:221–228.<br />
Mayer P, Hollt V (2001) Allelic and somatic variations in the endogenous opioid<br />
system of humans. Pharmacology and Therapeutics, 91:167–177.<br />
Mayer P y colab. (1997) Association between a <strong><strong>de</strong>l</strong>ta-opioid receptor gene polymorphism<br />
and heroin <strong>de</strong>pen<strong>de</strong>nce in man. Neuroreport, 8:2547–2550.<br />
Meller WH y colab. (1988) Specific familial transmission in substance abuse.<br />
The International Journal of the Addictions, 23:1029–1039.<br />
Merette C y colab. (1999) Evi<strong>de</strong>nce of linkage in subtypes of alcoholism. Genetic<br />
Epi<strong>de</strong>miology, 17(Suppl. 1):S253–S258.<br />
Merikangas KR y colab. (1998) Familial transmission of substance use disor<strong>de</strong>rs.<br />
Archives of General Psychiatry, 55:973–979.<br />
Merlo Pich E, Chiamulera C, Carboni L (1999) Molecular mechanisms of the<br />
positive reinforcing effect of nicotine. Behavioral Pharmacology, 10:587–596.<br />
Messina ES, Tyndale RF, Sellers EM (1997) A major role for CYP2A6 in nicotine<br />
C-oxidation by human liver microsomes. Journal of Pharmacology and<br />
Experimental Therapeutics, 282:1608–1614.<br />
Michelhaugh SK y colab. (2001) The dopamine transporter gene (SLC6A3)<br />
variable number of tan<strong>de</strong>m repeats domain enhances transcription in dopamine<br />
neurons. Journal of Neurochemistry, 79:1033–1038.<br />
Mihailescu S, Drucker-Colin R (2000) Nicotine, brain nicotinic receptors, and<br />
neuropsychiatric disor<strong>de</strong>rs. Archives of Medical Research, 31:131–144.<br />
Mikus G y colab. (1998) Relevance of <strong>de</strong>ficient CYP2D6 in opiate <strong>de</strong>pen<strong>de</strong>nce.<br />
Pharmacogenetics, 8:565–568.<br />
Mirin SM y colab. (1991) Psychopathology in drug abusers and their families.<br />
Comprehensive Psychiatry, 32:36–51.<br />
Miyamoto M y colab. (1999) CYP2A6 gene <strong><strong>de</strong>l</strong>etion reduces susceptibility to lung<br />
cancer. Biochemical and Biophysical Research Communications, 261:658–660.<br />
161
Change language